Overview

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Status:
Completed
Trial end date:
2019-02-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the long-term joint safety and efficacy (pain relief) of the investigational study drug, tanezumab compared to non-steroidal anti inflammatory drugs (NSAIDs) in subjects with osteoarthritis of the hips or knees.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Anti-Inflammatory Agents, Non-Steroidal
Celecoxib
Diclofenac
Naproxen
Tanezumab